vs
Axsome Therapeutics, Inc.（AXSM）与null（SWIM）财务数据对比。点击上方公司名可切换其他公司
Axsome Therapeutics, Inc.的季度营收约是null的2.0倍（$196.0M vs $100.0M），null净利率更高（-7.0% vs -14.6%，领先7.6%），Axsome Therapeutics, Inc.同比增速更快（65.0% vs 14.5%），null自由现金流更多（$14.1M vs $-18.7M），过去两年Axsome Therapeutics, Inc.的营收复合增速更高（61.7% vs -4.9%）
Jazz Pharmaceuticals是一家全球生物制药企业，专注于肿瘤学与神经科学领域的药物研发及商业化。公司2003年在美国加利福尼亚州成立，目前总部位于爱尔兰都柏林，业务覆盖全球多个核心市场。
该企业是一家源自美国的跨国律师事务所，1934年创立于加利福尼亚州洛杉矶，在诉讼业务、公司法务以及监管合规法律领域拥有深厚的行业积累与知名度，是全球颇具影响力的综合性律所之一。
AXSM vs SWIM — 直观对比
营收规模更大
AXSM
是对方的2.0倍
$100.0M
营收增速更快
AXSM
高出50.5%
14.5%
净利率更高
SWIM
高出7.6%
-14.6%
自由现金流更多
SWIM
多$32.8M
$-18.7M
两年增速更快
AXSM
近两年复合增速
-4.9%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $196.0M | $100.0M |
| 净利润 | $-28.6M | $-7.0M |
| 毛利率 | — | 28.0% |
| 营业利润率 | -13.8% | -10.7% |
| 净利率 | -14.6% | -7.0% |
| 营收同比 | 65.0% | 14.5% |
| 净利润同比 | 61.9% | 76.0% |
| 每股收益（稀释后） | $-0.55 | $-0.06 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收AXSMSWIM
| Q4 25 | $196.0M | $100.0M | ||
| Q3 25 | $171.0M | $161.9M | ||
| Q2 25 | $150.0M | $172.6M | ||
| Q1 25 | $121.5M | $111.4M | ||
| Q4 24 | $118.8M | $87.3M | ||
| Q3 24 | $104.8M | $150.5M | ||
| Q2 24 | $87.2M | $160.1M | ||
| Q1 24 | $75.0M | $110.6M |
净利润AXSMSWIM
| Q4 25 | $-28.6M | $-7.0M | ||
| Q3 25 | $-47.2M | $8.1M | ||
| Q2 25 | $-48.0M | $16.0M | ||
| Q1 25 | $-59.4M | $-6.0M | ||
| Q4 24 | $-74.9M | $-29.2M | ||
| Q3 24 | $-64.6M | $5.9M | ||
| Q2 24 | $-79.3M | $13.3M | ||
| Q1 24 | $-68.4M | $-7.9M |
毛利率AXSMSWIM
| Q4 25 | — | 28.0% | ||
| Q3 25 | — | 35.4% | ||
| Q2 25 | — | 37.1% | ||
| Q1 25 | — | 29.5% | ||
| Q4 24 | — | 24.6% | ||
| Q3 24 | — | 32.4% | ||
| Q2 24 | — | 33.1% | ||
| Q1 24 | — | 27.7% |
营业利润率AXSMSWIM
| Q4 25 | -13.8% | -10.7% | ||
| Q3 25 | -27.0% | 13.3% | ||
| Q2 25 | -24.5% | 14.3% | ||
| Q1 25 | -46.9% | -4.4% | ||
| Q4 24 | -61.1% | -14.9% | ||
| Q3 24 | -59.8% | 8.9% | ||
| Q2 24 | -89.5% | 12.5% | ||
| Q1 24 | -89.7% | -1.9% |
净利率AXSMSWIM
| Q4 25 | -14.6% | -7.0% | ||
| Q3 25 | -27.6% | 5.0% | ||
| Q2 25 | -32.0% | 9.3% | ||
| Q1 25 | -48.9% | -5.4% | ||
| Q4 24 | -63.1% | -33.4% | ||
| Q3 24 | -61.7% | 3.9% | ||
| Q2 24 | -91.0% | 8.3% | ||
| Q1 24 | -91.1% | -7.1% |
每股收益（稀释后）AXSMSWIM
| Q4 25 | $-0.55 | $-0.06 | ||
| Q3 25 | $-0.94 | $0.07 | ||
| Q2 25 | $-0.97 | $0.13 | ||
| Q1 25 | $-1.22 | $-0.05 | ||
| Q4 24 | $-1.54 | $-0.24 | ||
| Q3 24 | $-1.34 | $0.05 | ||
| Q2 24 | $-1.67 | $0.11 | ||
| Q1 24 | $-1.44 | $-0.07 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $322.9M | — |
| 总债务越低越好 | — | $279.8M |
| 股东权益账面价值 | $88.3M | $405.9M |
| 总资产 | $689.8M | $823.2M |
| 负债/权益比越低杠杆越低 | — | 0.69× |
8季度趋势，按日历期对齐
现金及短期投资AXSMSWIM
| Q4 25 | $322.9M | — | ||
| Q3 25 | $325.3M | — | ||
| Q2 25 | $303.0M | — | ||
| Q1 25 | $300.9M | — | ||
| Q4 24 | $315.4M | — | ||
| Q3 24 | $327.3M | — | ||
| Q2 24 | $315.7M | — | ||
| Q1 24 | $331.4M | — |
总债务AXSMSWIM
| Q4 25 | — | $279.8M | ||
| Q3 25 | — | $281.1M | ||
| Q2 25 | — | $281.5M | ||
| Q1 25 | — | $306.9M | ||
| Q4 24 | — | $281.5M | ||
| Q3 24 | — | $282.8M | ||
| Q2 24 | — | $282.4M | ||
| Q1 24 | — | $282.8M |
股东权益AXSMSWIM
| Q4 25 | $88.3M | $405.9M | ||
| Q3 25 | $73.7M | $408.4M | ||
| Q2 25 | $73.1M | $398.4M | ||
| Q1 25 | $53.2M | $381.1M | ||
| Q4 24 | $57.0M | $387.2M | ||
| Q3 24 | $92.9M | $416.6M | ||
| Q2 24 | $102.9M | $408.1M | ||
| Q1 24 | $144.0M | $391.8M |
总资产AXSMSWIM
| Q4 25 | $689.8M | $823.2M | ||
| Q3 25 | $669.3M | $844.4M | ||
| Q2 25 | $639.8M | $822.1M | ||
| Q1 25 | $596.7M | $824.6M | ||
| Q4 24 | $568.5M | $794.2M | ||
| Q3 24 | $561.5M | $853.4M | ||
| Q2 24 | $548.2M | $830.0M | ||
| Q1 24 | $545.7M | $808.6M |
负债/权益比AXSMSWIM
| Q4 25 | — | 0.69× | ||
| Q3 25 | — | 0.69× | ||
| Q2 25 | — | 0.71× | ||
| Q1 25 | — | 0.81× | ||
| Q4 24 | — | 0.73× | ||
| Q3 24 | — | 0.68× | ||
| Q2 24 | — | 0.69× | ||
| Q1 24 | — | 0.72× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-18.7M | $23.3M |
| 自由现金流经营现金流 - 资本支出 | $-18.7M | $14.1M |
| 自由现金流率自由现金流/营收 | -9.6% | 14.1% |
| 资本支出强度资本支出/营收 | 0.0% | 9.2% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-93.9M | $38.0M |
8季度趋势，按日历期对齐
经营现金流AXSMSWIM
| Q4 25 | $-18.7M | $23.3M | ||
| Q3 25 | $1.0M | $51.0M | ||
| Q2 25 | $-32.4M | $36.0M | ||
| Q1 25 | $-43.4M | $-46.9M | ||
| Q4 24 | $-26.2M | $6.2M | ||
| Q3 24 | $-18.6M | $37.2M | ||
| Q2 24 | $-30.1M | $52.4M | ||
| Q1 24 | $-53.5M | $-34.5M |
自由现金流AXSMSWIM
| Q4 25 | $-18.7M | $14.1M | ||
| Q3 25 | $988.0K | $45.2M | ||
| Q2 25 | $-32.4M | $29.1M | ||
| Q1 25 | $-43.7M | $-50.3M | ||
| Q4 24 | $-26.2M | $-98.0K | ||
| Q3 24 | $-18.7M | $33.2M | ||
| Q2 24 | $-30.2M | $47.9M | ||
| Q1 24 | $-53.6M | $-39.9M |
自由现金流率AXSMSWIM
| Q4 25 | -9.6% | 14.1% | ||
| Q3 25 | 0.6% | 27.9% | ||
| Q2 25 | -21.6% | 16.8% | ||
| Q1 25 | -36.0% | -45.2% | ||
| Q4 24 | -22.1% | -0.1% | ||
| Q3 24 | -17.9% | 22.1% | ||
| Q2 24 | -34.6% | 29.9% | ||
| Q1 24 | -71.4% | -36.0% |
资本支出强度AXSMSWIM
| Q4 25 | 0.0% | 9.2% | ||
| Q3 25 | 0.0% | 3.6% | ||
| Q2 25 | 0.0% | 4.0% | ||
| Q1 25 | 0.3% | 3.1% | ||
| Q4 24 | 0.0% | 7.2% | ||
| Q3 24 | 0.1% | 2.7% | ||
| Q2 24 | 0.1% | 2.8% | ||
| Q1 24 | 0.1% | 4.8% |
现金转化率AXSMSWIM
| Q4 25 | — | — | ||
| Q3 25 | — | 6.29× | ||
| Q2 25 | — | 2.25× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 6.32× | ||
| Q2 24 | — | 3.95× | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
AXSM
暂无分部数据
SWIM
| In Ground Swimming Pools | $50.2M | 50% |
| Covers | $37.0M | 37% |
| Liners | $12.7M | 13% |
